文献速递冠心病外科

多支冠状动脉病变患者按胸外科医师学会风险分层的结局

Outcomes in Multivessel Coronary Disease Stratified by The Society of Thoracic Surgeons Risk.
PubMed 文献 · Ann Thorac Surg · 2021-11-18

该回顾性观察分析纳入5836例多支冠状动脉病变患者,其中冠状动脉旁路移植术(CABG)4420例、经皮冠状动脉介入治疗(PCI)1416例,按胸外科医师学会风险评分分层。低风险与中高风险患者的5年死亡率在CABG和PCI组中均被报告,研究结论认为这些数据可帮助指导个体化血运重建策略选择。

要点

  • CABG组低风险患者5年死亡率为10.9%(95%CI 9.83%-12.05%),中高风险为40.1%(95%CI 35.76%-44.54%)。
  • PCI组低风险患者5年死亡率为21.6%(95%CI 19.10%-24.26%),中高风险为61.8%(95%CI 54.72%-68.70%)。
  • 作者认为这些按手术风险分层的结局数据可帮助指导个体患者血运重建策略的选择。

核心结论

  • 该研究报告了多支冠状动脉病变患者接受PCI或CABG后按手术风险分层的结局,作者认为这些数据可帮助指导个体患者的血运重建策略选择。

研究设计与样本

  • 回顾性观察分析,共纳入5836例多支冠状动脉病变患者,其中接受CABG者4420例、接受PCI者1416例。
  • 数据按胸外科医师学会风险评分分层,评分小于4%为低风险,大于或等于4%为中高风险。

主要发现

  • CABG组中低风险3863例(87.3%)、中高风险557例(12.6%);低风险队列5年死亡率为10.9%(95%CI 9.83%-12.05%),中高风险队列为40.1%(95%CI 35.76%-44.54%)。
  • PCI组中低风险1163例(82.1%)、中高风险249例(17.6%);低风险队列5年死亡率为21.6%(95%CI 19.10%-24.26%),中高风险队列为61.8%(95%CI 54.72%-68.70%)。

关键数值与推荐

  • 胸外科医师学会风险评分小于4%定义为低风险,大于或等于4%定义为中高风险。
  • 结局指标包括死亡率、住院再入院和再次血运重建。

临床怎么用

  • 作者认为这些按手术风险分层的结局数据可帮助指导个体患者血运重建策略的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical risk stratified outcomes after contemporary revascularization strategies have not been well described. We report these outcomes in patients undergoing percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) for multivessel coronary disease. METHODS: A total of 5836 patients with multivessel disease who underwent CABG (n = 4420) or PCI (n = 1416) were included in this retrospective observational analysis. Data were stratified based on The Society of Thoracic Surgeons risk score. A score less than 4% was considered low risk and a score greater than or equal to 4% was considered intermediate-high risk. Outcomes included mortality, inpatient readmissions, and repeat revascularizations. RESULTS: In the CABG population, 3863 (87.3%) were low risk and 557 (12.6%) were intermediate-high risk. The 5-year mortality for the low-risk cohort was 10.9% (95% confidence interval [CI], 9.83%-12.05%), and for the intermediate-high-risk cohort it was 40.1% (95% CI, 35.76%-44.54%). Among those undergoing PCI, 1163 (82.1%) were low risk, while 249 (17.6%) were intermediate-high risk. The 5-year mortality for the low-risk cohort was 21.6% (95% CI, 19.10%-24.26%), and for the intermediate-high-risk cohort it was 61.8% (95% CI, 54.72%-68.70%). CONCLUSIONS: This study reports outcomes stratified by surgical risk after PCI or CABG in patients with multivessel coronary disease. These data can help guide the revascularization strategy choice for individual patients.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Kapoor S, Zhu J, Kilic A, et al. Outcomes in Multivessel Coronary Disease Stratified by The Society of Thoracic Surgeons Risk. Ann Thorac Surg. 2021. PMID: 34801475. doi:10.1016/j.athoracsur.2021.08.084

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。